Lamotrigin Medochemie

Lamotrigine, the active ingredient in Lamotrigin Medochemie, is an Anticonvulsant presented as an oral tablet for oral use. It is used to treat partial seizures in epilepsy and as a maintenance therapy for bipolar disorder in adults. GNH USA supplies Lamotrigin Medochemie as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant that modulates neuronal excitability in several neurological and psychiatric conditions.

Epilepsy (partial seizures): reduces the frequency and severity of focal seizures. Bipolar disorder (maintenance therapy): helps stabilize mood and prevents recurrence of depressive or manic episodes.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions requiring immediate medical attention

Before initiating lamotrigine therapy, several safety considerations should be observed.

Monitor liver function: assess baseline hepatic enzymes and repeat as clinically indicated. Assess skin reactions: educate patients to report any rash promptly. Review concomitant valproate use: dose adjustments may be required. Adjust dose in renal impairment: consider reduced dosing in severe dysfunction. Avoid use in pregnancy unless essential: discuss potential risks with the prescriber. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproate: markedly increases lamotrigine levels, requiring dose reduction. - Carbamazepine: reduces lamotrigine exposure, potentially decreasing efficacy. - Phenytoin: lowers lamotrigine concentrations, may necessitate dose increase. - Phenobarbital: accelerates lamotrigine metabolism, reducing therapeutic effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, monitor seizure control. - Serotonergic agents: combined use can increase risk of serotonin syndrome. - NSAIDs: may raise the risk of skin reactions, observe for rash.